高危T1期结直肠癌局部切除与手术切除的长期结局:系统评价与荟萃分析
该系统评价与荟萃分析纳入12项研究,比较高危T1期结直肠癌患者局部切除与手术切除的长期生存结局。局部切除组长期死亡风险(HR 2.06)、复发风险(HR 3.51)和癌相关死亡风险(HR 2.31)均高于手术切除组。拟合生存曲线显示,除5年疾病特异性生存外,其余各时点结局差异均有统计学意义;作者认为观察期超过10年时手术切除的疾病特异性生存净获益似乎显著,局部切除对部分高危T1期结直肠癌患者可能是合理的个体化治疗选择。
要点
- 高危T1期结直肠癌局部切除组长期死亡风险高于手术切除组(HR 2.06)。
- 局部切除组复发风险(HR 3.51)和癌相关死亡风险(HR 2.31)均高于手术切除组。
- 拟合曲线示除5年疾病特异性生存外各结局差异均有统计学意义。
核心结论
- 对高危T1期结直肠癌患者,观察期超过10年时手术切除的疾病特异性生存净获益似乎显著。
- 长期净获益可能存在,但可能不适用于所有患者,尤其是合并症多的高危患者。
- 作者认为局部切除对部分高危T1期结直肠癌患者可能是合理的个体化治疗选择。
研究设计与样本
- 系统检索已对高危T1期结直肠癌患者局部切除与手术切除进行生存分析的研究。
- 提取总生存、无复发生存和疾病特异性生存数据,并拟合生存曲线。
- 荟萃分析共纳入12项研究。
主要发现
- 与手术切除组相比,局部切除组长期死亡风险更高(HR 2.06;95%CI 1.59-2.65)。
- 与手术切除组相比,局部切除组复发风险更高(HR 3.51;95%CI 2.51-4.93)。
- 与手术切除组相比,局部切除组癌相关死亡风险更高(HR 2.31;95%CI 1.17-4.54)。
- 拟合曲线5年、10年、20年总生存率局部切除组分别为86.3%、72.9%、61.8%,手术切除组分别为94.5%、84.4%、71.1%。
- 拟合曲线5年、10年、20年无复发生存率局部切除组分别为89.9%、83.3%、29.6%,手术切除组分别为96.9%、93.9%、90.8%;疾病特异性生存率局部切除组分别为96.7%、86.9%、86.9%,手术切除组分别为98.3%、97.1%、96.4%。
临床怎么用
- 作者认为局部切除对部分高危T1期结直肠癌患者可能是合理的个体化治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with T1 colorectal cancer (CRC) are at high risk for lymph node metastasis and recurrence after local resection (LR) and need surgical resection (SR) for additional lymph node dissection to improve prognosis. However, the net benefits of SR and LR are still unquantified. METHODS: We conducted a systematic search for studies in which survival analysis among high-risk T1 CRC patients undergoing LR and SR was performed. Overall survival (OS), recurrence-free survival (RFS), and disease-specific survival (DSS) data were extracted. Hazard ratios (HRs) and fitted survival curves for OS, RFS, and DSS were used to estimate the long-term clinical outcomes of patients in the 2 groups. RESULTS: This meta-analysis included 12 studies. Compared with those in the SR group, patients in the LR group had higher risks of death (HR, 2.06; 95% confidence interval [CI], 1.59-2.65), recurrence (HR, 3.51; 95% CI, 2.51-4.93), and cancer-related mortality (HR, 2.31; 95% CI, 1.17-4.54) in the long term. Fitted survival curves for the LR and SR groups revealed the 5-year, 10-year, and 20-year rates for OS (86.3% and 94.5%, 72.9% and 84.4%, and 61.8% and 71.1%), RFS (89.9% and 96.9%, 83.3% and 93.9%, and 29.6% and 90.8%), and DSS (96.7% and 98.3%, 86.9% and 97.1%, and 86.9% and 96.4%). Log-rank tests showed significant differences among all outcomes except 5-year DSS. CONCLUSIONS: For high-risk T1 CRC patients, the net benefit of DSS appears to be significant when the observation period exceeds 10 years. A long-term net benefit may exist but may not be applicable to all patients, especially high-risk patients with comorbidities. Therefore, LR may be a reasonable alternative for individualized treatment for some high-risk T1 CRC patients.
引用
- Chen Y, Jing W, Chen M, et al. Long-term outcomes of local resection versus surgical resection for high-risk T1 colorectal cancer: a systematic review and meta-analysis. Gastrointest Endosc. 2023. PMID: 36863572. doi:10.1016/j.gie.2023.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。